FT Vest U.S. Equity Deep Buffer ETF – October (BATS:DOCT) Trading 0.1% Higher – Here’s Why

Shares of FT Vest U.S. Equity Deep Buffer ETF – October (BATS:DOCTGet Free Report) shot up 0.1% on Monday . The company traded as high as $39.11 and last traded at $39.04. 51,179 shares traded hands during trading, The stock had previously closed at $39.01.

FT Vest U.S. Equity Deep Buffer ETF – October Stock Down 0.2 %

The firm has a market cap of $190.34 million, a PE ratio of 23.49 and a beta of 0.46. The firm’s fifty day simple moving average is $38.96 and its two-hundred day simple moving average is $38.46.

Institutional Trading of FT Vest U.S. Equity Deep Buffer ETF – October

An institutional investor recently raised its position in FT Vest U.S. Equity Deep Buffer ETF – October stock. Wealth Enhancement Advisory Services LLC boosted its stake in shares of FT Vest U.S. Equity Deep Buffer ETF – October (BATS:DOCTFree Report) by 72.1% in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 15,922 shares of the company’s stock after buying an additional 6,672 shares during the quarter. Wealth Enhancement Advisory Services LLC owned approximately 0.34% of FT Vest U.S. Equity Deep Buffer ETF – October worth $599,000 as of its most recent SEC filing.

FT Vest U.S. Equity Deep Buffer ETF – October Company Profile

(Get Free Report)

The FT Cboe Vest U.S. Equity Deep Buffer ETF – October (DOCT) is an exchange-traded fund that mostly invests in large cap equity. The fund aims for specific buffered losses and capped gains on the SPY over a specific holdings period. The actively-managed fund holds options and collateral. DOCT was launched on Oct 16, 2020 and is managed by First Trust.

Featured Stories

Receive News & Ratings for FT Vest U.S. Equity Deep Buffer ETF - October Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for FT Vest U.S. Equity Deep Buffer ETF - October and related companies with MarketBeat.com's FREE daily email newsletter.